Skip to content

22.02.2011

?8A0=85 ?@5?0@0B0 803@0 (!8;45=0D8;)

?8A0=85 ?@5?0@0B0 803@0 (!8;45=0D8;)

803@0 (!8;45=0D8;0 F8B@0B), ?> 60;C9 A09 48ADC=:F88 8;8 3> 15AA8;8O. 07@01>B0==K9 8 >4>1@5==K9 : ?@>872>4AB2C :>;55 G5< 45AOB8;5B85 =0704. 803@0 1K;0 ?@54?8A0=0 4;O 1;CAB865=85< 8 ?> 445@60=85< M@5:F88. "01;5B:8 803@0 AB0;8 =0AB>;L:> ?>?C;O@=K, GB> 8E <>6=> :C?8BL ?>GB8 2> 2A5E 0?B5:0E.

0: 803@0 (A8;45=0D8;) @01>B05B?
!8;45=0D8;0 F8B@0B 8<55B >G5=L ?@>AB>9 <5B>4 @01>BK, >= >AB0=02;8205B @01>BC ?@8@>4=>3> D5@<5=B0 D>AD>48MAB5@07C 2 >@30=87<5 AD>48MAB5@070 B0:65 ?@8ACBAB2C5B 2 ?5=8A5 340 >=0 >:07K205B A2>5 2;8O=85, 2OBAO =5 2 A>AB>O=88 ?>445@6820BL A2>N M@5:F8N. 803@0 (A8;45=0D8;) >AB0=02;8205B 459AB285 D>AD>48MAB5@07K, 2 @57C;LB0B5 G53> <>65B 4>AB8GL 74>@>2>9 M@5:F88.

5@2>=0G0;L=0O F5;L :> A>740=85 ;5:0@AB20 4;O ;5G5=8O ;53>G=>9 0@B5@80;L=>9 38?5@B5=788. > :0: B>;L:> 1K;> >1=0@C65=>, GB> ?@5?0@0B B0:65 MDD5:B825= C = 1K; =0?@02;5= =0 >4>1@5=85 2 FDA (#?@02;5=85 ?> =047>@C ;5:0@AB2 8 <548:0<5=B>2), 345 8 ?>;CG8; ?0B5=B :0: ?@5?0@0B 4;O ;5G5=8O M@5:B8;L=>9 48ADC=:F88. ! B5E ?>@ 803@0 ?@>4>;605B >AB020BLAO A0?C;O@=K< 8 H8@>:> 8A?>;L7C5< 4;O ;5G5=8O 9 8B5=F88.

>1>G=K5 MDD5:BK 803@K
803@0 :0: 8 2A5 ;5:0@AB20, 8<55B =5:>B>@K5 ?> 1>G=K5 MDD5:BK. 7028A8<>AB8 >B ?@8=OB>9 4>78@>2:8, A83CB 1KBL :0: A8;L=K<8, B0: 8 C<5@5==K<8. >B =5:>B>@K9 ?> 1>G=K5 MDD5:BK :>B>@K5 8A?KBK20NB =0 A515 1>;LH8=AB2> ?0F85=B>2 ?@8=8<02H8E 2803@C: ?>ABL : A25BC, @0AAB@>9AB2> 65;C4:0, 480@5O, 3>;>2=K5 1>;8, 70;>65==>ABL =>A0.

5@54>78@>2:0 <>65B 1KBL >A>15==> 2@54=0, 4;O <8 701>;520=8O<8, B0:85 ;N48 4>;6=K 2A5340 ?@845@6820BLAO ?@54?8A0==>9 4>7K. >A;54=55, => =5 <5=55 206=>, ;5:0@AB2> 803@0 ?@54=07=0G5=0 B>;L:> 4;O 27@>A;KE ;6=> C?>B@51;OBLAO <8 2 2>7@0AB5 4> 18 ;5B.

5:><5=40F88 ?5@54 ?@8<5=5=85<
803@5 >1KG=> B@51C5BAO 30-45 <8=CB 4;O =0G0;> 55 459AB28O, 2 8450;5 65 2803@0 4>;6=0 1KBL C?>B@51;5=0 70 >48= G0A 4> A5:AC0;L=>9 0:B82=>AB8.

0:>20 4>78@>2:0 803@K (A8;45=0D8;)?
1KG=0O 4>78@>2:0 2803@K 4;O ;5G5=8O 9 8B5=F88 A>AB02;O5B 100 <3 (1 B01;5B:0).

07=8F0 <564C 1@5=4 8 465=5@8: 803@>9
> A>AB02C 465=5@8:8 8 >@838=0;L=0O 2803@0 =8G5< =5 >B;8G05BAO, A>AB02 465=5@8:>2 =0 99% 845=B8G5= A >@838=0;L=K<8 ?@5?0@0B0<8 (1% O2;ONBAO =50:B82=K5 8=3@5485=BK). 87C0;L=K5 >B;8G8O 465=5@8:>2 MB> F25B, D>@<0 8 C?0:>2:0 B01;5B>:. 65=5@8: 2803@0 4>ABC?=0 ?> 1>;55 =87:8< F5=0< 8 C65 CA?5;0 702>520BL @>AA89A:89 @K=>:, :0: =0456=K9 8 ?@8OB=K9 ?> F5=5 ?@5?0@0B.

45 8 :0: :C?8BL 803@C?
0H 8=B5@=5B <03078= ?@54;0305B 20< A0< ;5:0@AB20 >?B>< =0 702>40E 873>B>28B5;OE, 8<5NI8E A5@B8D8:0BK FDA. @57C;LB0B5 <>65< A=878BL F5=C 4;O =0H8E :;85=B>2 4> 110 @C1. 70 B01;5B:C, 0 B0:65 AB2;O5< 1>=CAK 8 A:84:8! 0:070BL 465=5@8: 2803@C A 4>AB02:>9 :C@L5@>< ?> >A:25 8 5B5@1C@3C 8;8 ?>GB>9 ?> 2A59 >AA88.

0B53>@8O: @5?0@0BK

Share your thoughts, post a comment.

(required)
(required)

Note: HTML is allowed. Your email address will never be published.

Subscribe to comments